NASDAQ:UROY - Nasdaq - CA91702V1013 - Common Stock - Currency: USD
3.1
+0.05 (+1.64%)
The current stock price of UROY is 3.1 USD. In the past month the price increased by 24.5%. In the past year, price increased by 34.2%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
CCJ | CAMECO CORP | 165.83 | 34.65B | ||
NXE | NEXGEN ENERGY LTD | N/A | 4.16B | ||
CNR | CORE NATURAL RESOURCES INC | 12.92 | 4.11B | ||
LEU | CENTRUS ENERGY CORP-CLASS A | 42.36 | 4.11B | ||
UEC | URANIUM ENERGY CORP | N/A | 3.96B | ||
ARLP | ALLIANCE RESOURCE PARTNERS | 12.49 | 3.59B | ||
UUUU | ENERGY FUELS INC | N/A | 2.17B | ||
BTU | PEABODY ENERGY CORP | 7.95 | 2.03B | ||
DNN | DENISON MINES CORP | N/A | 1.99B | ||
NRP | NATURAL RESOURCE PARTNERS LP | 9.62 | 1.32B | ||
HNRG | HALLADOR ENERGY CO | N/A | 695.85M | ||
EU | ENCORE ENERGY CORP | N/A | 568.66M |
Uranium Royalty Corp. operates as an exploration company. The company is headquartered in Vancouver, British Columbia and currently employs 14 full-time employees. The company went IPO on 2019-12-06. The firm is focused on gaining exposure to uranium prices by making strategic investments in uranium interests, including royalties, streams, debt and equity investments in uranium companies, as well as through holdings of physical uranium. Its portfolio includes Anderson, Church Rock, Cigar Lake/Waterbury Lake, Dawn Lake, Dewey-Burdock, Energy Queen, Lance, Langer Heinrich, McArthur River, Michelin, Reno Creek and others. The Anderson Project is an advanced stage conventional uranium project, covering 8,268 acres, and is in Yavapai County, west-central Arizona, approximately 75 miles northwest of Phoenix and 43 miles northwest of Wickenburg. The Churchrock Project is an advanced stage, in-situ recovery uranium project located in the Grants Mineral Belt of New Mexico, USA, 12 miles northeast of Gallup, New Mexico. The company has royalty interests in the Millennium and Cree Extension Uranium Projects in Saskatchewan.
URANIUM ROYALTY CORP
1830 - 1188 West Georgia Street, Suite 1830
Vancouver BRITISH COLUMBIA CA
CEO: Scott Melbye
Employees: 14
Phone: 16046301000
The current stock price of UROY is 3.1 USD. The price increased by 1.64% in the last trading session.
The exchange symbol of URANIUM ROYALTY CORP is UROY and it is listed on the Nasdaq exchange.
UROY stock is listed on the Nasdaq exchange.
8 analysts have analysed UROY and the average price target is 3.42 USD. This implies a price increase of 10.23% is expected in the next year compared to the current price of 3.1. Check the URANIUM ROYALTY CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
URANIUM ROYALTY CORP (UROY) has a market capitalization of 414.28M USD. This makes UROY a Small Cap stock.
URANIUM ROYALTY CORP (UROY) currently has 14 employees.
URANIUM ROYALTY CORP (UROY) has a support level at 2.46. Check the full technical report for a detailed analysis of UROY support and resistance levels.
The Revenue of URANIUM ROYALTY CORP (UROY) is expected to decline by -2.12% in the next year. Check the estimates tab for more information on the UROY EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
UROY does not pay a dividend.
URANIUM ROYALTY CORP (UROY) will report earnings on 2025-09-10.
URANIUM ROYALTY CORP (UROY) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.03).
The outstanding short interest for URANIUM ROYALTY CORP (UROY) is 12.6% of its float. Check the ownership tab for more information on the UROY short interest.
ChartMill assigns a technical rating of 9 / 10 to UROY. When comparing the yearly performance of all stocks, UROY is one of the better performing stocks in the market, outperforming 91.99% of all stocks.
ChartMill assigns a fundamental rating of 2 / 10 to UROY. While UROY seems to be doing ok healthwise, there are quite some concerns on its profitability.
Over the last trailing twelve months UROY reported a non-GAAP Earnings per Share(EPS) of -0.03. The EPS decreased by -154.12% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -1.91% | ||
ROE | -1.92% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 78% to UROY. The Buy consensus is the average rating of analysts ratings from 8 analysts.
For the next year, analysts expect an EPS growth of -349.93% and a revenue growth -2.12% for UROY